S.C. Ropharma Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Mihai Miron
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 17yrs |
| CEO ownership | 14.1% |
| Management average tenure | 16yrs |
| Board average tenure | 19yrs |
Recent management updates
Recent updates
S.C. Ropharma (BVB:RPH) Is Experiencing Growth In Returns On Capital
Dec 06
Here's What's Concerning About S.C. Ropharma's (BVB:RPH) Returns On Capital
Dec 09S.C. Ropharma (BVB:RPH) Is Reinvesting At Lower Rates Of Return
Sep 23Is S.C. Ropharma (BVB:RPH) Using Too Much Debt?
Jun 01Some Investors May Be Worried About S.C. Ropharma's (BVB:RPH) Returns On Capital
Mar 16S.C. Ropharma (BVB:RPH) Takes On Some Risk With Its Use Of Debt
May 15S.C. Ropharma (BVB:RPH) Might Be Having Difficulty Using Its Capital Effectively
Mar 26Should You Be Impressed By S.C. Ropharma's (BVB:RPH) Returns on Capital?
Dec 23
We Wouldn't Rely On S.C. Ropharma's (BVB:RPH) Statutory Earnings As A Guide
Nov 24CEO
Mihai Miron (65 yo)
Dr. Pharmacist. Mihai Miron serves as Chairman since 2009 and Chief Executive Officer of Ropharma SA.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 17yrs | no data | 14.07% RON 13.7m | |
| CFO & Member of the Board of Directors | 16yrs | no data | no data | |
| HR Director & Member of Board of Directors | 14yrs | no data | no data |
Experienced Management: RPH's management team is seasoned and experienced (16 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 17yrs | no data | 14.07% RON 13.7m | |
| CFO & Member of the Board of Directors | 19yrs | no data | no data | |
| HR Director & Member of Board of Directors | 19yrs | no data | no data | |
| Member of the Board of Directors | 19yrs | no data | no data | |
| Member of the Board of Directors | 17yrs | no data | no data | |
| Member of the Board of Directors | 19yrs | no data | no data | |
| Member of the Board of Directors | 9.8yrs | no data | no data |
Experienced Board: RPH's board of directors are seasoned and experienced ( 19 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/05 00:24 |
| End of Day Share Price | 2026/01/05 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
S.C. Ropharma S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.